Robot arm takes on rectal cancer in tiny trial

NCT ID NCT06591572

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tested a new, less invasive robotic surgery for mid and low rectal cancer. Twenty patients underwent the procedure to see if it was safe and feasible. The surgery uses a single-port robot through the anus, combined with standard laparoscopic or robotic tools in the abdomen. The main goals were to check for complications during and within 30 days after surgery, and to see if the procedure could be completed as planned without switching to open surgery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
single-port robotic transanal total mesorectal excision (a surgical procedure)
What this could lead to
If successful, this could offer a less invasive surgical option for rectal cancer patients, potentially leading to quicker recovery and fewer complications.
What could go wrong
This is a very early, small study (20 patients) with no comparison group. The procedure is complex and may not be suitable for all patients. Risks include surgical complications and the need to convert to open surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huichao Zheng

    Chongqing, 400042, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.